Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Burkhardt UE"'
Autor:
Burkhardt UE; Accelerating Cancer Immunotherapy Research, Concord, MA, USA. ute.burkhardt@acir.org., Fritsch EF; Accelerating Cancer Immunotherapy Research, Concord, MA, USA. ed.fritsch@acir.org.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. ed.fritsch@acir.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. ed.fritsch@acir.org.
Publikováno v:
Genes and immunity [Genes Immun] 2023 Dec; Vol. 24 (6), pp. 292-294. Date of Electronic Publication: 2023 Dec 11.
Autor:
Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Burkhardt UE; Accelerating Cancer Immunotherapy Research, Cambridge, Massachusetts., Hacohen N; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. cwu@partners.org.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2020 Dec; Vol. 8 (12), pp. 1465-1469.
Autor:
Hu Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Anandappa AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Sun J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Leet DE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Bozym DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Chen C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Williams L; Broad Institute of MIT and Harvard, Cambridge, MA., Shukla SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA., Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Tabbaa D; Broad Institute of MIT and Harvard, Cambridge, MA., Steelman S; Broad Institute of MIT and Harvard, Cambridge, MA., Olive O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Livak KJ; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA., Kishi H; Department of Immunology, University of Toyama, Toyama, Japan., Muraguchi A; Department of Immunology, University of Toyama, Toyama, Japan., Guleria I; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Stevens J; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Lane WJ; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Burkhardt UE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Neuberg D; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA; and., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA; and., Hacohen N; Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Massachusetts General Hospital, Boston, MA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA; and.
Publikováno v:
Blood [Blood] 2018 Nov 01; Vol. 132 (18), pp. 1911-1921. Date of Electronic Publication: 2018 Aug 27.
Autor:
Xiaoling Li1,2,3 lixiaoling@tmu.edu.cn, Jian You4,5, Liping Hong1,2,3, Weijiang Liu1,2,3, Peng Guo1,2,3, Xishan Hao1,2,3,6 xishanhao@sina.com
Publikováno v:
Cancer Biology & Medicine. Apr2024, Vol. 21 Issue 4, p274-311. 38p.
Autor:
Bachireddy P; 1] Department of Medical Oncology and the Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. [2] Broad Institute, Cambridge, Massachusetts 02142, USA. [3] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA., Burkhardt UE; Department of Medical Oncology and the Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA., Rajasagi M; 1] Department of Medical Oncology and the Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. [2] Broad Institute, Cambridge, Massachusetts 02142, USA. [3] Bristol-Meyers Squibb, Princeton, New Jersey 08540, USA., Wu CJ; 1] Department of Medical Oncology and the Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. [2] Broad Institute, Cambridge, Massachusetts 02142, USA. [3] Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Publikováno v:
Nature reviews. Cancer [Nat Rev Cancer] 2015 Apr; Vol. 15 (4), pp. 201-15. Date of Electronic Publication: 2015 Mar 19.
Autor:
von La Roche, Dominik, Schumacher, Magdalena, Kohn, Marina, Trapp, Johanna, Schusser, Benjamin, Rautenschlein, Silke, Härtle, Sonja
Publikováno v:
Frontiers in Immunology; 2024, p1-22, 22p
Autor:
Wang, Ruyuan, Lan, Caini, Benlagha, Kamel, Camara, Niels Olsen Saraiva, Miller, Heather, Kubo, Masato, Heegaard, Steffen, Lee, Pamela, Yang, Lu, Forsman, Huamei, Li, Xingrui, Zhai, Zhimin, Liu, Chaohong
Publikováno v:
MedComm; Oct2024, Vol. 5 Issue 10, p1-37, 37p
Autor:
Kloke BP; Ribological GmbH, Hölderlinstraße 8, 55131, Mainz, Germany, bjoern.kloke@ribological.de., Rae R, Mahr A, Burkhardt UE, Kvistborg P, Britten CM
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2014 Jul; Vol. 63 (7), pp. 749-55. Date of Electronic Publication: 2013 Nov 05.
Autor:
Burkhardt UE; Department of Medical Oncology; Cancer Vaccine Center; Dana-Farber Cancer Institute; Boston, MA USA., Wu CJ; Department of Medical Oncology; Cancer Vaccine Center; Dana-Farber Cancer Institute; Boston, MA USA ; Department of Medicine; Brigham and Women's Hospital; Harvard Medical School; Boston, MA USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2013 Nov 01; Vol. 2 (11), pp. e26587. Date of Electronic Publication: 2013 Oct 10.
Autor:
Burkhardt UE; Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA., Hainz U, Stevenson K, Goldstein NR, Pasek M, Naito M, Wu D, Ho VT, Alonso A, Hammond NN, Wong J, Sievers QL, Brusic A, McDonough SM, Zeng W, Perrin A, Brown JR, Canning CM, Koreth J, Cutler C, Armand P, Neuberg D, Lee JS, Antin JH, Mulligan RC, Sasada T, Ritz J, Soiffer RJ, Dranoff G, Alyea EP, Wu CJ
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2013 Sep; Vol. 123 (9), pp. 3756-65. Date of Electronic Publication: 2013 Aug 05.